pI: 10.8484 |
Length (AA): 105 |
MW (Da): 12585 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
26 | 75 | 3k3v (A) | 17 | 66 | 30.00 | 0.53 | 0.05 | 0.66889 | 1.05 |
70 | 105 | 3ihj (A) | 48 | 83 | 53.00 | 0 | 0.3 | 0.690957 | 1.82 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127112)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G72330 | alanine aminotransferase 2 |
Arabidopsis thaliana | AT1G17290 | alanine aminotransferase |
Arabidopsis thaliana | AT1G23310 | glutamate:glyoxylate aminotransferase |
Arabidopsis thaliana | AT1G70580 | glutamate--glyoxylate aminotransferase 2 |
Candida albicans | CaO19.346 | putative alanine aminotransferase |
Candida albicans | CaO19.7979 | putative alanine aminotransferase |
Caenorhabditis elegans | CELE_C32F10.8 | Protein C32F10.8, isoform B |
Dictyostelium discoideum | DDB_G0285899 | alanine aminotransferase |
Drosophila melanogaster | Dmel_CG1640 | CG1640 gene product from transcript CG1640-RB |
Escherichia coli | b2290 | valine-pyruvate aminotransferase 2 |
Echinococcus granulosus | EgrG_000317500 | alanine aminotransferase 2 |
Entamoeba histolytica | EHI_159710 | alanine aminotransferase, putative |
Echinococcus multilocularis | EmuJ_000317500 | alanine aminotransferase 2 |
Giardia lamblia | GL50803_12150 | Alanine aminotransferase, putative |
Giardia lamblia | GL50803_16363 | Alanine aminotransferase, putative |
Homo sapiens | ENSG00000167701 | glutamic-pyruvate transaminase (alanine aminotransferase) |
Homo sapiens | ENSG00000166123 | glutamic pyruvate transaminase (alanine aminotransferase) 2 |
Leishmania braziliensis | LbrM.12.0630 | alanine aminotransferase |
Leishmania donovani | LdBPK_120580.1 | alanine aminotransferase, putative |
Leishmania infantum | LinJ.12.0580 | alanine aminotransferase |
Leishmania major | LmjF.12.0630 | alanine aminotransferase |
Leishmania mexicana | LmxM.12.0630 | alanine aminotransferase, putative |
Loa Loa (eye worm) | LOAG_14583 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13624 | hypothetical protein |
Loa Loa (eye worm) | LOAG_14412 | hypothetical protein |
Mycobacterium leprae | ML2502 | PROBABLE ASPARTATE AMINOTRANSFERASE ASPC (TRANSAMINASE A) (ASPAT) |
Mus musculus | ENSMUSG00000022546 | glutamic pyruvic transaminase, soluble |
Mus musculus | ENSMUSG00000031700 | glutamic pyruvate transaminase (alanine aminotransferase) 2 |
Mycobacterium tuberculosis | Rv0337c | Probable aspartate aminotransferase AspC (transaminase A) (ASPAT) |
Mycobacterium ulcerans | MUL_0573 | aminotransferase AlaT |
Neospora caninum | NCLIV_024040 | Aminotransferase (EC 2.6.1.-), related |
Oryza sativa | 4347138 | Os09g0433900 |
Oryza sativa | 4348524 | Os10g0390500 |
Oryza sativa | 4342210 | Os07g0108300 |
Oryza sativa | 4343916 | Os07g0617800 |
Onchocerca volvulus | OVOC1454 |
|
Saccharomyces cerevisiae | YLR089C | alanine transaminase ALT1 |
Saccharomyces cerevisiae | YDR111C | alanine transaminase ALT2 |
Schistosoma japonicum | Sjp_0018880 | ko:K00814 alanine transaminase [EC2.6.1.2], putative |
Schistosoma japonicum | Sjp_0308320 | Alanine aminotransferase 2, putative |
Schistosoma mansoni | Smp_007760 | alanine aminotransferase |
Schmidtea mediterranea | mk4.002901.04 | Alanine aminotransferase, putative |
Schmidtea mediterranea | mk4.002317.00 | Alanine aminotransferase, putative |
Schmidtea mediterranea | mk4.044997.00 | Tyrosine aminotransferase |
Schmidtea mediterranea | mk4.001571.05 | Alanine aminotransferase, putative |
Trypanosoma brucei gambiense | Tbg972.1.2510 | alanine aminotransferase, putative |
Trypanosoma brucei | Tb927.1.3950 | alanine aminotransferase |
Trypanosoma congolense | TcIL3000_1_1620 | alanine aminotransferase, putative |
Trypanosoma cruzi | TcCLB.510889.120 | glutamic--pyruvic transaminase, putative |
Trypanosoma cruzi | TcCLB.506529.430 | alanine aminotransferase, putative |
Trypanosoma cruzi | TcCLB.510889.140 | glutamic--pyruvic transaminase, putative |
Trypanosoma cruzi | TcCLB.506529.420 | alanine aminotransferase, putative |
Toxoplasma gondii | TGME49_264030 | aminotransferase, putative |
Trichomonas vaginalis | TVAG_098820 | tyrosine aminotransferase, putative |
Trichomonas vaginalis | TVAG_074600 | tyrosine aminotransferase, putative |
Trichomonas vaginalis | TVAG_379550 | tyrosine aminotransferase, putative |
Trichomonas vaginalis | TVAG_132440 | alanine aminotransferase, putative |
Trichomonas vaginalis | TVAG_088220 | aspartate aminotransferase, putative |
Trichomonas vaginalis | TVAG_136210 | alanine aminotransferase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.1.3950 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.3950 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.3950 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.1.3950 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2290 | Escherichia coli | non-essential | goodall |
CELE_C32F10.8 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C32F10.8 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C32F10.8 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_264030 | Toxoplasma gondii | Probably non-essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.